Benjamin Ferrer Noom upgrades GLP-1 weight management app features as digital therapeutics gain US market traction Benjamin Ferrer Weight management app Noom has revealed a major update to its GLP-1 Companion service to accompany and optimize popular GLP-1 drug therapies, which can cause temporary and long-term side effects like critical nutritional gaps and muscle loss
In contrast, REM sleep becomes more intense and extensive towards the end of the sleep period
Animals with natural myostatin mutations, including Belgian Blue cattle and certain dog breeds, develop 200-300% more skeletal muscle than normal
A dual GLP-1 and GIP receptor agonist, such as tirzepatide, stimulates both GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors
Body Weight Reduction in Women Treated with Tirzepatide by Reproductive Stage: A Post Hoc Analysis from the SURMOUNT Program. Obesity , 12 Mar
The effect tends to be strongest once you reach a regular maintenance dose